|
|
12 Health Care Stocks Moving In Monday's After-Market Session
|
|
|
|
Dow Tumbles Over 700 Points; Dominion Energy Posts Upbeat Earnings
|
|
|
|
12 Health Care Stocks Moving In Monday's Intraday Session
|
|
|
|
Gossamer Bio Plans FDA Talks After Narrow Miss In Key Pivotal Study, Stock Sinks
|
|
|
|
US Stocks Mixed; Domino's Pizza Shares Gain After Q4 Earnings
|
|
|
|
Gossamer Bio shares are trading lower. The company announced topline results for the PROSERA Phase 3 Study of seralutinib in patients with PAH.
|
|
|
|
Trading Halt: Halt status updated at 8:25:00 AM ET: Quotation Resumption: News and Resumption Times
|
|
|
|
Gossamer Bio Announces Results For PROSERA Phase 3 Study Of Seralutinib In Patients With PAH
|
|
|
|
Trading Halt: Halted at 7:58:21 a.m. ET - Trading Halt: Halt News Pending
|
|
|
|
Barclays Initiates Coverage On Gossamer Bio with Overweight Rating, Announces Price Target of $9
|
|